Capital International’s Puma Biotechnology PBYI Stock Holding History

Capital International’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-139,897	Closed	-$11M	–	188
2015 Q4	$11M	Sell	139,897 -5,800	-4%	-$455K	0.69%	47
2015 Q3	$11M	Buy	145,697 +54,762	+60%	+$5.18M	0.73%	47
2015 Q2	$10.6M	Buy	90,935 +28,200	+45%	+$5.11M	0.63%	52
2015 Q1	$14.8M	Buy	62,735 +7,335	+13%	+$1.57M	0.9%	41
2014 Q4	$10.5M	Buy	+55,400	New	+$12.3M	0.64%	53

Other funds holding PBYI

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return